DSGN icon

Design Therapeutics

83 hedge funds and large institutions have $413M invested in Design Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.82M
Puts
$1.24M
Net Calls
Net Calls Change

Top Buyers

1 +$21.8M
2 +$9.23M
3 +$3.85M
4
Bank of America
Bank of America
North Carolina
+$2.35M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$2.18M

Top Sellers

1 -$19.5M
2 -$16.8M
3 -$7.64M
4
Goldman Sachs
Goldman Sachs
New York
-$7.38M
5
TCM
Tekla Capital Management
Massachusetts
-$4.69M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.3M
27
$1.16M
28
$1.13M
29
$1.12M
30
$965K
31
$850K
32
$594K
33
$585K
34
$530K
35
$521K
36
$425K
37
$360K
38
$358K
39
$312K
40
$283K
41
$251K
42
$251K
43
$226K
44
$203K
45
$183K
46
$181K
47
$164K
48
$163K
49
$162K
50
$160K